Prevalence of olfactory and taste dysfunction in COVID-19 patients: a community care facility study
- PMID: 33595697
- PMCID: PMC7886642
- DOI: 10.1007/s00405-021-06647-2
Prevalence of olfactory and taste dysfunction in COVID-19 patients: a community care facility study
Abstract
Purpose: We aim to study the prevalence of olfactory and taste dysfunction (OTD) in subjects residing in a Community Care Facility (CCF), a center unique to Singapore that is dedicated to isolate foreign workers with COVID-19 infection who have mild disease with minimal or no symptoms.
Methods: This is a cross-sectional study analyzing data prospectively collected from COVID-19-positive subjects who were admitted into a single-center Singapore EXPO CCF from 1st May 2020 to 1st July 2020. The following variables were collected: age, gender, ethnicity, anosmia, ageusia and acute respiratory infection (ARI) symptoms. Symptoms of anosmia and ageusia were self-declared via a mandatory questionnaire administered on admission.
Results: A total of 1983 subjects were included. The overall prevalence of anosmia and ageusia is 3.0% and 2.6%, respectively. 58% of anosmic subjects have co-existent ageusia and 72.6% of anosmic subjects have no concurrent sinonasal symptoms. OTD is less likely to present in subjects who are asymptomatic for ARI, compared to those symptomatic for ARI (anosmia: 2.0% versus 4.4% p = 0.002; ageusia: 1.6% versus 4.2% p < 0.001). There is a difference in the prevalence of OTD between the different ethnic groups (Indian, Chinese, Bangladeshi and Others), with Chinese and Bangladeshi reporting a higher prevalence (p < 0.043) CONCLUSION: The true prevalence of OTD in COVID-19-positive subjects may be low with aggressive screening of all subjects, including those asymptomatic for ARI.
Keywords: Ageusia; Anosmia; Asymptomatic; COVID-19; Coronavirus; Dysfunction; Olfactory; Smell; Taste.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.
Conflict of interest statement
The authors have no conflict of interest to disclose.
Figures
References
-
- World Health Organization (2020) Coronavirus disease (COVID-2019) situation reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio.... Accessed 10 Aug 2020
-
- Centres for Disease Control and Prevention (2020) Coronavirus disease 2019 (COVID-19) symptoms. Published April 17, 2020. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html. Accessed 22 Apr 2020
-
- Welge-Lüssen A, Wolfensberger M. Olfactory disorders following upper respiratory tract infections. Adv Otorhinolaryngol. 2006;63(1):125–132. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical